A photo showing the logo of Swiss pharmaceutical giant Roche in Basel.
SEBASTIEN BOZON | AFP | Getty Images
Swiss pharmaceutical giant Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly.
The U.S. takeover target’s most promising drug candidate, a once-a-week injection called CT-388, belongs to a class known as a dual GLP-1/GIP receptor agonist, the same as Lilly’s Mounjaro, or Zepbound.
After encouraging Phase I trial results, the drug is ready to be tested on humans in the second of three trial stages, Roche added in a statement on Monday.
Pioneer Novo is ahead in the market with obesity drug Wegovy, a single agonist of the GLP-1 gut hormone receptor, and is scrambling to boost production amid overwhelming demand in an obesity market that analysts estimate could reach as much as $100 billion in annual revenues.
Roche shares opened up 1.75%, hitting a six-week high on optimism that the weight-loss market will accommodate many rivals.
“Competition in the fast-growing obesity and diabetes markets should heat up quickly. The markets are large enough for ‘me too’ products, particularly when offered at the right price,” Zuercher Kantonalbank analysts said in a note.
Roche said in its statement CT-388 could become the best in its class to treat obesity and its comorbidities.
Among recent deals to acquire obesity drug development projects, AstraZeneca last month agreed to pay up to $2 billion for the rights to an experimental pill from China’s Eccogene.
New Roche CEO Thomas Schinecker has set a high deal pace since taking the helm in March to restore Roche’s drug development pipeline, which was hit by major late-stage trial setbacks in Alzheimer’s and cancer immunotherapy last year.
Roche in October agreed to pay an initial $7.1 billion to Roivant and Pfizer for rights to a new inflammatory bowel disease drug, eyeing new therapeutic fields to offset falling oncology sales.
On top of the upfront purchase price of $2.7 billion, the owners of unlisted Carmot will receive payments of up to $400 million if certain milestones are achieved, the Swiss drugmaker said.
Carmot was co-founded by long-time CEO Stig Hansen in 2008. While keeping a Carmot board seat, Hansen this year became CEO of Kimia Therapeutics, an entity that was spun out of Carmot to focus on the discovery of new metabolic diseases drugs.
Carmot’s current portfolio includes clinical stage gut-hormone drugs, in pill and injection form, aimed at treating obesity in patients with and without diabetes, as well as a number of programs not yet tested on humans, Roche said.
Carmot’s employees will join Roche’s pharmaceuticals division when the transaction officially closes, expected in the first quarter of 2024.
Roche will obtain access to Carmot’s current R&D portfolio including all clinical and preclinical assets.
Austin Butler Says ‘Dune 2’ Set Was ‘110 Degrees’ on His First Week and ‘There Were People Passing Out From Heat Stroke’: ‘It Became a Microwave’
Jeff Bezos unloads around $2.4 billion in Amazon stock, bringing recent sales to 50 million shares
Trump Can’t Stop Comparing Himself to Alexei Navalny
Trump says NY civil fraud fine against him is ‘a form of Navalny’
The Best Spring Decor for a Major Home Refresh
Why Americans Suddenly Stopped Hanging Out
New Jersey residents stocking up for several inches of snow; Winter Storm Warnings for multiple counties
Are Sprouted Potatoes Safe to Eat, or Are You Risking a Major Illness?
Does Working Out Really Make Botox Wear Off Faster?
Tiger Woods signs apparel and footwear deal with TaylorMade following his split with Nike
Royal Commentator Believes Prince Harry and Meghan’s Recent Public Appearances Show They Are in ‘Dire Straits’ Over Their Future
’90 Day Fiancé’: Mary and Brandan Delete Fundraiser After Fans Question Colon Cancer Announcement
Prince Harry ‘Just Learned How to Pay His Own Phone Bill’ and Really ‘Needs Media Training,’ Commentator Says
‘Love Is Blind’: Chelsea Blackwell Regrets Megan Fox Comparison
Measles Strikes a Florida Elementary School With Over 100 Unvaccinated Kids
Lifestyle14 hours ago
Celebrate National Love Your Pet Day With These Paws-ome Gifts
News13 hours ago
The Strictly stars we’ve loved and lost: After dancer Robin Windsor’s shock death is revealed, a look at the other legends of the BBC show who have sadly passed away
News14 hours ago
Istanbul marks 110th anniversary since 1st tram hit roads
News14 hours ago
News14 hours ago
Oligarchs ‘fear Putin more than losing their billions’ – Asia Times
News14 hours ago
Wild goats on rise amid conservation efforts in Türkiye’s Bingöl
News24 hours ago
2 dead in crash near University of South Florida
News23 hours ago
Plant-based meat, non-alcoholic drinks: What the future of food in UAE looks like